1. Home
  2. VLN vs BDTX Comparison

VLN vs BDTX Comparison

Compare VLN & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valens Semiconductor Ltd.

VLN

Valens Semiconductor Ltd.

N/A

Current Price

$1.48

Market Cap

188.2M

Sector

Technology

ML Signal

N/A

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

N/A

Current Price

$2.61

Market Cap

220.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VLN
BDTX
Founded
2006
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.2M
220.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VLN
BDTX
Price
$1.48
$2.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$3.00
$10.60
AVG Volume (30 Days)
482.1K
1.6M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.38
Revenue
$67,887,000.00
$70,000,000.00
Revenue This Year
$21.84
N/A
Revenue Next Year
$11.96
N/A
P/E Ratio
N/A
$6.93
Revenue Growth
7.53
N/A
52 Week Low
$1.37
$1.20
52 Week High
$3.50
$4.94

Technical Indicators

Market Signals
Indicator
VLN
BDTX
Relative Strength Index (RSI) 36.53 29.41
Support Level $1.66 $2.61
Resistance Level $1.75 $2.84
Average True Range (ATR) 0.07 0.25
MACD -0.01 -0.04
Stochastic Oscillator 1.79 22.59

Price Performance

Historical Comparison
VLN
BDTX

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Cross Industry Business, which includes solutions for the non-automotive verticals, including audio-video, industrial, machine vision and medical markets, that deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: